Cargando…
MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1
BACKGROUND: Anaplastic thyroid cancer (ATC) is considered to be a rare type of thyroid cancer but takes up the most important proportion of thyroid cancer-related deaths. Therefore, the development of molecular targeted therapy is an exciting strategy in the management of ATC. METHODS: miR-155 and S...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852915/ https://www.ncbi.nlm.nih.gov/pubmed/31718618 http://dx.doi.org/10.1186/s12885-019-6319-4 |